Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions and methods for oral administration of cannabinoids and terpenoids

a technology of cannabinoids and terpenoids, which is applied in the directions of macromolecular non-active ingredients, plant/algae/fungi/lichens ingredients, oil/fat/waxes non-active ingredients, etc., can solve the problems of slow action, often exacerbated problems, and compositions that are slow to act, and achieve fast action, precise and reliable dosage, and the effect of feeling the effect of the consumer both quickly and easily

Inactive Publication Date: 2021-03-18
TRINIDAD CONSULTING LLC
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes an orally administered cannabis product that has precise and reliable dosage, fast action, and can be felt by consumers quickly and for an hour or longer. This product is safe to ingest and allows for the combination of water soluble cannabinoids and terpenoids with non-derivatized cannabinoids and terpenoids in any useful ratios to produce complex effects.

Problems solved by technology

However most users of edible cannabis find that it has undesirable characteristics including slow action, often requiring an hour or more before effects are felt, and unpredictable dosing.
These problems are often exacerbated by users who subsequently consume additional quantities in the mistaken belief that their initial dose was inadequate.
Unfortunately the resulting compositions continue to be slow acting because of the low water solubility of cannabinoids.
Although effective, each of these techniques has its limitations ranging from discomfort to toxicity.
Terpenoids therefore present similar opportunities for derivatizations that increase water solubility and speed of effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0056]In an embodiment, an orally administered cannabinoid and terpenoid composition may be prepared according to the following procedure. Fat soluble ingredients including 15 parts vegetable glyercine, 15 parts coconut oil, and 1.5 parts orange essential oil are combined over medium heat with stirring. To this preparation is added 10 parts non derivatized D-limonene extracted and purified from cannabis flowers in a liquid preparation at 100 mg / ml.

[0057]Water soluble ingredients are combined in a separate container over medium heat with stirring as follows, 5 parts citric acid, 5 parts concentrated fruit flavoring, and 10 parts fine sugar. When fully dissolved and mixed, 10 parts esterified THCΔ9 derived from organic synthesis and present in a liquid preparation at 100 mg / ml is added to the solution. Once the water soluble components are thoroughly mixed they are slowly combined with a solution of lecithin representing 5 parts of the final preparation.

[0058]When the water soluble an...

example 2

[0060]In another embodiment it is preferable to significantly reduce oil used in the orally administered cannabinoid and terpenoid composition which may be prepared according the following procedure. The following components, 40 parts concentrated mint flavoring, 1 part coenzyme Q10, 10 parts Eucalyptol, 10 parts ester derivatized CBD prepared as a hydrochloride salt, and 10 parts pentyl side chain derivatized Cannabichromene also prepared as a hydrochloride salt, are combined over gentle heating in an aqueous solution. When the components are fully dissolved into solution they are added to an automatic mixer containing 20 parts finely ground com husk fiber. The combined ingredients are mixed at high speed for 5 minutes and then 9 parts of agar is added to the mixture and it is mixed for another 30 minutes. The resulting preparation is then added a pouching machine and dispensed to animal fiber pouches in 1 g allotments containing 100 mg CBD, 100 mg CBC and 100 mg Eucalyptol.

example 3

[0061]In yet another embodiment it may be preferable to more accurately control dosing by adding the cannabinoid and terpenoid concentrates to the composition following the packaging step. In this embodiment the following components, 30 parts concentrated cinnamon flavoring and 10 parts caffeine, 10 parts nicotine oil are combined over gentle heating in a dilute alcohol solution. After the components are fully combined they are added to an automatic mixer containing 20 parts finely ground hemp fiber. The combined ingredients are mixed at high speed for 5 minutes and then 10 parts gelatin is added to the mixture and it is then mixed for another 30 minutes. The resulting preparation is then added a pouching machine and dispensed to nylon fiber pouches in 1 g allotments. The finished pouches are gently dehydrated and then positioned so that each may be treated with a quantity of water soluble cannabinoid and terpenoid concentrate in liquid form. Next 10 parts Nerolidol in a liquid prep...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to oral administration of water soluble cannabinoid and terpenoid concentrates on a flavored fibrous carrier. The compositions described herein provide an alternative to smoked cannabis that also avoid the slow action and unpredictable dosing of edible cannabis preparations. Water soluble concentrates of cannabinoids and terpenoids may be produced by derivatization reactions which are known in the art. Such water soluble concentrates enjoy significantly increased absorption by mucosal membranes of the mouth and may therefore be experienced by the consumer more quickly. Water soluble cannabinoid and terpenoid concentrates may be used in combination with each other and in combination with non-derivatized molecules which provides the user with fast and slow acting components in a single delivery vehicle.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. application Ser. No. 15 / 904,356 filed Feb. 24, 2018; which claims priority to U.S. Provisional Application No. 62 / 463,151 filed Feb. 24, 2017. The contents of these applications are incorporated herein by reference in their entirety as if set forth verbatim.FIELD OF INVENTION[0002]The market for products containing cannabis and extracts thereof has grown significantly in the wake of widespread medical and recreational legalization. In addition to cannabis flowers which are usually consumed by smoking, there are now a range of cannabis concentrates, a variety of edible products as well as eye drops and transdermal patches to name a few.BACKGROUND OF THE INVENTION[0003]Many cannabis smokers desire smokeless alternatives because of the cumulative adverse effects of smoking. Until recently the main alternative to smoked cannabis was edible cannabis. However most users of edible cannabis find that it ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K9/00A61K36/185A61K47/44A61K47/06A61K47/46A61K47/38A61K31/235A23L33/105A61K31/352A61K47/24A61K47/36A61K47/42
CPCA61K9/0056A61K36/185A61K47/44A61K47/06A61K47/46A61K47/38A23V2002/00A23L33/105A61K31/352A61K9/009A61K47/24A61K47/36A61K47/42A61K31/235
Inventor MANDEL, CASE MICHAELSAMMET, CLIFTON ANTON
Owner TRINIDAD CONSULTING LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com